Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A single index chart move often signals momentum shifts; understanding its implications helps traders frame positions and adapt risk controls.
26,274 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Florida moves to curb risky AI use, setting the stage for OpenAI’s next legal battle. The actions could alter how inv...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
South Korea's crypto scene is under new scrutiny as the south korean police book Bithumb's CEO in a bribery probe lin...
NuScale has become a polarizing name in energy investing, swinging between hype and risk. This guide breaks down the ...
Ripple secures a key regulatory foothold in Luxembourg, signaling EU-wide expansion. XRP ETFs continue drawing instit...
As the Senate nears its August recess, crypto firms race lock on the CLARITY Act, pushing for a floor vote before law...
SoFi Technologies is navigating a volatile market as it heads into Q2 results, with analysts signaling potential upsi...
AscendEX has suspended all operations as of July 1, 2026, warning users that full balance recovery cannot be guarante...
Applied Optoelectronics and Lumentum surged as Texas expansion plans lift demand for AI optics components, boosting r...
Two popular names in tech and space economics spark a debate: should you buy SpaceX stock while selling Micron stock,...
Bitcoin remains volatile as investors weigh its evolving role; market voices describe the asset's current stage as a ...